drugset

drugset / Trial / NCT04304313

A Pilot Study of Sildenafil in COVID-19

NCT04304313 ↗

Phase 3 Unknown 10 enrolled Tongji Hospital

NaSingle-groupOpen-labelTreatment

Summary

Observe the efficacy and safety of G1(Sildenafil citrate tablets) in patients with COVID-19 under clinical actual diagnosis and treatment conditions

Timeline

Start: 2020-02-09
Primary completion: 2020-03-01
Completion: 2020-11-09

Publications

Sultana J, Crisafulli S, Gabbay F, Lynn E, Shakir S, Trifiro G. Challenges for Drug Repurposing in the COVID-19 Pandemic Era. Front Pharmacol. 2020 Nov 6;11:588654. doi: 10.3389/fphar.2020.588654. eCollection 2020.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Sildenafil	Unknown	0.1 g	—

Indications